QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

VNDA

QT56Vanda Pharmaceuticals Inc.
NASDAQ·Healthcare·Biotechnology·USA
Latest market price
5.80
-0.16-2.68%
OverviewShort InterestFilings
VNDAQT56Vanda Pharmaceuticals Inc.·NASDAQ
OverviewShort InterestFilings
5.80-2.68%
TA
Loading chart...
Screen all →
VRTX-1.60%$451.63REGN+0.33%$609.94ARGX-1.63%$877.72ALNY-1.64%$278.09RVMD+3.31%$162.99MRNA+3.50%$63.96UTHR-2.70%$536.59BNTX-1.44%$90.89
Snapshot
Index-P/E-EPS (ttm)
-4.05
Insider Own-
Shs Outstand60.14M
Perf Week-4.92%
Market Cap358.41MForward P/E-EPS next Y-0.76Insider Trans-Shs Float-Perf Month-3.17%
Enterprise Value317.45MPEG0.01EPS next Q-0.58Inst Own-Short Float-Perf Quarter-32.32%
Income-242283774.00P/S1.65EPS this Y44.38%Inst Trans-Short Ratio-Perf Half Y-12.78%
Sales217.79MP/B1.26EPS next Y66.15%ROA-55.26%Short Interest-Perf YTD-34.24%
Book/sh4.67P/C-EPS next 5Y-ROE-61.41%52W High9.94 -41.65%Perf Year29.18%
Cash/sh3.36P/FCF-EPS past 3/5Y-ROIC-52.76%52W Low4.14 40.10%Perf 3Y-
Dividend Est.-EV/EBITDA-2.33Sales past 3/5Y-5.26% -2.73%Gross Margin92.46%Volatility3.32% 2.86%Perf 5Y-
Dividend TTM-EV/Sales1.46EPS Y/Y TTM-562.50%Oper. Margin-73.64%ATR (14)0.29Perf 10Y-
Dividend Ex-Date-Quick Ratio2.15Sales Y/Y TTM9.55%Profit Margin-109.99%RSI (14)39.67Recom2.37
Dividend Gr. 3/5Y-Current Ratio2.16EPS Q/Q-64.00%SMA20-5.28%Beta0.96Target Price14.25
Payout0.00%Debt/Eq0.05Sales Q/Q4.00%SMA50-11.39%Rel Volume1.60Prev Close5.96
Employees368LT Debt/Eq0.02EarningsJul 30SMA200-9.29%Avg Volume1.08MPrice5.80
IPO DateApr 12, 2006Option/ShortYes / YesEPS/Sales Surpr.-54.72% -5.45%Net Debt/EBITDA0.30Volume1,728,920Change-2.68%
Analyst Ratings
DateActionAnalystRatingTarget
May-11-26ReiteratedH.C. WainwrightBuy$24 → $21
Feb-23-26ReiteratedH.C. WainwrightBuy$22 → $24
Jan-05-26ReiteratedH.C. WainwrightBuy$20 → $22
Dec-31-25ReiteratedJefferiesHold$7.50
Nov-05-25ReiteratedB.Riley Financial$11
Jul-11-24InitiatedCantor FitzgeraldOverweight$11
Feb-25-22DowngradeJefferiesBuy → Hold
Jan-14-21DowngradeCitigroupBuy → Neutral
Oct-29-20UpgradeCitigroupNeutral → Buy
Jun-09-20DowngradeCitigroupBuy → Neutral
Latest News
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue218216199
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A161311
Gross Profit201203187
Selling, General and Administrative Excl. Other256238146
Research and Development10210974
Other Operating Expense578
Operating Income-160-151-41
Interest Expense
000
Unusual Expense
———
Non-Operating Income (Expense)-11-13-18
Net Income Before Taxes-149-139-23
Income Taxes8982-4
Consolidated Net Income-240-220-19
Net Income From Continuing Operations-240-220-19
Net Income-240-220-19
EPS (Recurring)-4.05-3.74-0.32
EPS (Basic, Before Extraordinaries)-4.05-3.74-0.32
EPS (Diluted)-4.05-3.74-0.32
EBITDA-136-127-15
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio1.572.41—
Gross Margin92.2093.9893.97
Operating Margin-73.39-69.91-20.60
Net Margin-110.09-101.85-9.55
Shares Outstanding595958
Market Capitalization342520—
Operating Lease Expense
———
Insider Trading Volume
$6.17$5.39$4.61$3.83$3.05● Close Price0.00K0.00K0.00K0.00K0.00KUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR